Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125614682 | 12561468 | 2 | F | 2015 | 20160829 | 20160715 | 20160913 | EXP | US-BAYER-2016-136064 | BAYER | 0.00 | F | Y | 0.00000 | 20160913 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125614682 | 12561468 | 1 | PS | ACETYLSALICYLIC ACID({=100 mg) | ASPIRIN | 1 | Oral | 81 MG, QD | U | 999999 | 81 | MG | TABLET | QD | |||||
| 125614682 | 12561468 | 2 | SS | HYZAAR | HYDROCHLOROTHIAZIDELOSARTAN POTASSIUM | 1 | Oral | UNK UNK, QD | 0 | QD | |||||||||
| 125614682 | 12561468 | 3 | SS | HYDROXYZINE HYDROCHLORIDE. | HYDROXYZINE HYDROCHLORIDE | 1 | Oral | 25 MG, QD | 0 | 25 | MG | QD | |||||||
| 125614682 | 12561468 | 4 | SS | SINGULAIR | MONTELUKAST SODIUM | 1 | Oral | 10 MG, QD | 0 | 10 | MG | QD | |||||||
| 125614682 | 12561468 | 5 | SS | CITALOPRAM HYDROBROMIDE. | CITALOPRAM HYDROBROMIDE | 1 | 40 MG, QD | 0 | 40 | MG | QD | ||||||||
| 125614682 | 12561468 | 6 | SS | LYRICA | PREGABALIN | 1 | 200 MG, BID | 0 | 200 | MG | BID | ||||||||
| 125614682 | 12561468 | 7 | SS | LYRICA | PREGABALIN | 1 | 75 MG, TID | 0 | 75 | MG | TID | ||||||||
| 125614682 | 12561468 | 8 | SS | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | 25 MG, BID | 0 | 25 | MG | BID | ||||||||
| 125614682 | 12561468 | 9 | SS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | 40 MG, BID | 0 | 40 | MG | BID | ||||||||
| 125614682 | 12561468 | 10 | SS | CALCIUM W/VITAMIN D NOS | CALCIUMVITAMIN D | 1 | 500 MG, BID | 0 | 500 | MG | BID | ||||||||
| 125614682 | 12561468 | 11 | SS | POTASSIUM CHLORIDE. | POTASSIUM CHLORIDE | 1 | 20 MEQ, QD | 0 | 20 | MEQ | QD | ||||||||
| 125614682 | 12561468 | 12 | SS | ACYCLOVIR [ACICLOVIR SODIUM] | ACYCLOVIR | 1 | 400 MG, TID | 0 | 400 | MG | TID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125614682 | 12561468 | 1 | Cardiac disorder |
| 125614682 | 12561468 | 2 | Hypertension |
| 125614682 | 12561468 | 3 | Anxiety |
| 125614682 | 12561468 | 4 | Asthma |
| 125614682 | 12561468 | 5 | Depression |
| 125614682 | 12561468 | 6 | Pain |
| 125614682 | 12561468 | 7 | Pain |
| 125614682 | 12561468 | 8 | Fluid retention |
| 125614682 | 12561468 | 9 | Gastrooesophageal reflux disease |
| 125614682 | 12561468 | 12 | Infection |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125614682 | 12561468 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125614682 | 12561468 | Pain |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125614682 | 12561468 | 1 | 2009 | 0 | ||
| 125614682 | 12561468 | 2 | 2014 | 0 | ||
| 125614682 | 12561468 | 3 | 2013 | 0 | ||
| 125614682 | 12561468 | 4 | 2014 | 0 | ||
| 125614682 | 12561468 | 5 | 2013 | 0 | ||
| 125614682 | 12561468 | 6 | 2015 | 0 | ||
| 125614682 | 12561468 | 7 | 2015 | 0 | ||
| 125614682 | 12561468 | 8 | 2015 | 0 | ||
| 125614682 | 12561468 | 9 | 2009 | 0 | ||
| 125614682 | 12561468 | 10 | 2013 | 0 | ||
| 125614682 | 12561468 | 11 | 2013 | 0 | ||
| 125614682 | 12561468 | 12 | 2014 | 0 |